Previous Article | Next Article ![]()
Journal of Virology, March 2000, p. 2121-2130, Vol. 74, No. 5
Molecular Oncology Group, Lady Davis
Institute for Medical Research,1
Microbiology and Biotechnology Research Center, INRS-Institut
Armand-Frappier,2 Departments of
Medicine3 and Microbiology and
Immunology,4 McGill University, and
Division of Hematology-Oncology, Sir Mortimer B. Davis
Jewish General Hospital,5 Montréal,
Québec, Canada
Received 4 August 1999/Accepted 4 December 1999
Human immunodeficiency virus type 1 (HIV-1) infection triggers a
cytotoxic T-lymphocyte (CTL) response mediated by CD8+ and
perhaps CD4+ CTLs. The mechanisms by which HIV-1 escapes
from this CTL response are only beginning to be understood. However, it
is already clear that the extreme genetic variability of the virus is a
major contributing factor. Because of the well-known ability of altered
peptide ligands (APL) to induce a T-cell receptor (TCR)-mediated
anergic state in CD4+ helper T cells, we investigated the
effects of HIV-1 sequence variations on the proliferation and cytotoxic
activation of a human CD4+ CTL clone (Een217) specific for
an epitope composed of amino acids 410 to 429 of HIV-1 gp120. We report
that a natural variant of this epitope induced a functional anergic
state rendering the T cells unable to respond to their antigenic ligand
and preventing the proliferation and cytotoxic activation normally
induced by the original antigenic peptide. Furthermore, the stimulation
of Een217 cells with this APL generated altered TCR-proximal signaling events that have been associated with the induction of T-cell anergy in
CD4+ T cells. Importantly, the APL-induced anergic state of
the Een217 T cells could be prevented by the addition of interleukin 2, which restored their ability to respond to their nominal antigen. Our data therefore suggest that HIV-1 variants can induce a state of anergy
in HIV-specific CD4+ CTLs. Such a mechanism may allow a
viral variant to not only escape the CTL response but also facilitate
the persistence of other viral strains that may otherwise be recognized
and eliminated by HIV-specific CTLs.
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
T-Cell Receptor-Mediated Anergy of a Human Immunodeficiency Virus
(HIV) gp120-Specific CD4+ Cytotoxic T-Cell Clone,
Induced by a Natural HIV Type 1 Variant Peptide
*
Corresponding author. Mailing address: Lady Davis
Institute for Medical Research, 3755 Côte Ste-Catherine Rd.,
Montréal, Québec, Canada H3T 1E2. Phone: (514) 340-8260. Fax: (514) 340-7573. E-mail:
CCouture{at}ldi.jgh.mcgill.ca.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»